Publication Name	World Journal of Critical Care Medicine
Manuscript ID	94707
Country	India

Received	2024-03-23 11:23
Peer-Review Started	2024-03-23 11:23
To Make the First Decision
Return for Revision	2024-04-22 22:22
Revised	2024-04-26 00:36
Second Decision	2024-05-11 02:40
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-05-11 10:52
Articles in Press	2024-05-11 10:52
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-05-27 00:51
Publish the Manuscript Online	2024-06-03 10:23

ISSN	2220-3141(online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Clinical Neurology
Manuscript Type	Minireviews
Article Title	Serotonin syndrome controversies: A need for consensus
Manuscript Source	Invited Manuscript
All Author List	Sanjay Prakash, Chetsi S Shah and Anurag Prakash
Funding Agency and Grant Number
Corresponding Author	Sanjay Prakash, DM, Professor, Department of Neurology, Smt. B.K. Shah Medical Institute and Research Centre, Sumandeep Vidyapeeth, Piparia, Waghodia, Vadodara 391760, Gujarāt, India. drprakashs@yahoo.co.in
Key Words	Serotonin; Serotonin syndrome; Serotonin toxicity; Selective serotonin reuptake inhibitors; Antidepressants; Cyproheptadine
Core Tip	Many recent papers have highlighted new developments in serotonin syndrome (SS). New clinical findings and clinical scenarios have emerged. Cases are now being reported from non-psychiatric and non-toxicological centers. SS can occur at therapeutic and stable doses. They create considerable diversity in various aspects of SS. Some experts, meanwhile, dismiss these recent advancements in SS. Because SS is a potentially fatal illness, there must be agreement on various issues of SS.
Publish Date	2024-06-03 10:23
Citation	<p>Prakash S, Shah CS, Prakash A. Serotonin syndrome controversies: A need for consensus. <i>World J Crit Care Med</i> 2024; 13(2): 94707</p>
URL	https://www.wjgnet.com/2220-3141/full/v13/i2/94707.htm
DOI	https://dx.doi.org/10.5492/wjccm.v13.i2.94707

Full Article (PDF)	WJCCM-13-94707-with-cover.pdf
Manuscript File	94707_Auto_Edited-JLW.docx
Answering Reviewers	94707-answering-reviewers.pdf
Audio Core Tip	94707-audio.m4a
Conflict-of-Interest Disclosure Form	94707-conflict-of-interest-statement.pdf
Copyright License Agreement	94707-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	94707-non-native-speakers.pdf
Peer-review Report	94707-Peer-review(s).pdf
Scientific Misconduct Check	94707-Bing-Liu H-2.png
Scientific Editor Work List	94707-Scientific editor work list.pdf
CrossCheck Report	94707-CrossCheck report.pdf